Healthcare (SH:603313) Shang Hai Zheng Quan Bao·2025-08-25 19:59Group 1 - The company has reported a total of 2,912.94 million yuan in asset impairment provisions for the first half of 2025, which will reduce the total profit for the period by the same amount [63][64][66] - The impairment provisions include 2,636.10 million yuan for accounts receivable, 251.99 million yuan for inventory, and 24.85 million yuan for goodwill [64][65][66] - The company emphasizes that the data is unaudited and the final accounting treatment will be based on the annual audit results [64][66] Group 2 - The company plans to hold a performance briefing on September 12, 2025, to discuss the first half of 2025 results and address investor questions [69][70][72] - The briefing will be conducted via video and online interaction, allowing investors to submit questions in advance [70][72] - Key company executives, including the chairman and financial director, will participate in the briefing [71][72] Group 3 - The company has approved the use of up to 80 million yuan of idle raised funds for cash management, with a usage period not exceeding 12 months [46][49][60] - The cash management aims to improve the efficiency of fund usage without affecting the normal implementation of investment projects [48][60] - The company will ensure that the cash management products are safe, liquid, and have a term not exceeding 12 months [55][60] Group 4 - The company has reported a total of 58,169.67 million yuan in cumulative used raised funds as of June 30, 2025, with a remaining balance of 20,367.48 million yuan [36][37] - The company has established a special account for raised funds and signed regulatory agreements with banks to ensure proper management [39][40] - The company has not encountered any abnormal situations regarding the investment projects funded by the raised funds [40]